Structural Basis of Signal Instigation Through Family C GPCRs
通过 C 族 GPCR 激发信号的结构基础
基本信息
- 批准号:10767205
- 负责人:
- 金额:$ 6.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-15 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAgonistAminobutyric AcidsBindingBinding ProteinsBinding SitesBiochemicalBiological AssayCell membraneCentral Nervous SystemCentral Nervous System DiseasesCommunicationComplementComplexCoupledCouplesCouplingCryoelectron MicroscopyCysteine-Rich DomainDefectDetergentsDiseaseDrug AddictionEnvironmentExtracellular DomainFamilyFunctional disorderG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGRM5 geneGTP-Binding ProteinsGlutamate ReceptorGlutamatesHeterotrimeric GTP-Binding ProteinsKnowledgeLengthLigand BindingLinkLipidsMapsMembraneMental DepressionMetabotropic Glutamate ReceptorsMicellesMolecularMolecular ConformationMutagenesisMutationNerve DegenerationNeurologicPainParkinson DiseasePhospholipidsPhysiologicalPreparationPropertyProteinsProtomerReceptor ActivationRepressionResolutionRoleSchizophreniaSideSignal TransductionSiteSpecificityStructureSynaptic TransmissionSynaptic plasticitySystemTestingTransmembrane DomainVenusWorkcombatcomputer studiesconformational conversiondesigndimerdrug discoveryextracellularflygamma-Aminobutyric Acidin vitro Assayinsightmetabotropic glutamate receptor 2metabotropic glutamate receptor type 1molecular dynamicsnanodiskneuronal excitabilityneuropsychiatryneurotransmissionnovel therapeutic interventionpharmacologicprotein activationprotein complexreceptorreceptor couplingreceptor functionrelease of sequestered calcium ion into cytoplasmstructural determinantstherapeutic target
项目摘要
Abstract
The γ-aminobutyric acid B receptor (GABABR) and the metabotropic glutamate receptors (mGluRs) belong to
the Family C of G protein coupled receptors (GPCRs) and critically regulate neuronal excitability, synaptic
transmission and plasticity. Many disorders of the CNS have been linked to alterations in neuronal excitability
via the glutamatergic and GABAergic system. Accordingly, mGluRs and GABABR have been the subject of an
enormous drug discovery effort as they represent major therapeutic targets for treating numerous physiological
dysfunctions and for neurodegenerative and neuropsychiatric conditions. Apart from the prototypical seven
transmembrane helix (7TM) domain, Family C GPCRs also include a large extracellular ‘venus fly trap’ (VFT)
domain that constitutes the orthosteric ligand binding site. Binding of ligand to the extracellular VFT domain
triggers a large conformational change in the VFT domains from an open to a closed conformation. This clam-
shell like closure of the extracellular domain results in receptor engagement and activation of G proteins on the
intracellular side of the transmembrane domain with a mechanism that remains unclear. Receptor activated G
proteins then act to either enhance or repress secondary messenger signaling cascades. We recently showed
cryoEM structures of near-full length mGluR5 and GABABR in inactive and active conformations, revealing
extensive transitions in the organization of the 7TM dimer upon ligand binding to the VFT. Notwithstanding this
progress, several key questions remain regarding the allosteric communication across the cell membrane by
Family C GPCRs, and particularly the mechanism of G protein coupling and activation. To address these
questions, we propose to obtain the structures of mGluR2, mGluR5 and GABABR in complex with their cognate
G proteins and probe the structural insights using molecular dynamics simulations and mutagenesis coupled to
functional assays. The similarities and differences amongst these receptor-G protein complexes will allow us to
contrast and compare our findings and examine aspects of G protein coupling and selectivity. Collectively,
these studies will enable us to create a detailed mechanistic framework to understand Family C GPCR
signaling and will form the basis for the design of novel therapeutic strategies targeting these receptors.
摘要
γ-氨基丁酸B受体(GABABR)和代谢型谷氨酸受体(mGluRs)属于
G蛋白偶联受体(GPCRs)C家族和关键调节神经元兴奋性、突触
传输和可塑性。许多中枢神经系统疾病与神经元兴奋性的改变有关
通过谷氨酸能和γ-氨基丁酸能系统因此,mGluRs和GABABR已经成为一个研究的主题。
巨大的药物发现努力,因为它们代表了治疗许多生理性疾病的主要治疗靶点。
功能障碍和神经退行性疾病和神经精神疾病。除了典型的七个
跨膜螺旋(7 TM)结构域,家族C GPCR还包括一个大的细胞外“venus fly trap”(VFT)
结构域,其构成正构配体结合位点。配体与细胞外VFT结构域的结合
触发VFT结构域从开放构象到闭合构象的大的构象变化。这只蛤蜊-
细胞外结构域的壳状闭合导致受体接合和G蛋白在细胞外表面上的活化。
细胞内侧的跨膜结构域的机制仍不清楚。受体激活G
然后蛋白质起作用以增强或抑制第二信使信号级联。我们最近展示了
近全长mGluR 5和GABABR在非活性和活性构象中的cryoEM结构,揭示了
配体与VFT结合后,7 TM二聚体的组织发生了广泛的转变。尽管如此
尽管研究进展缓慢,但关于细胞膜上的变构通讯仍存在几个关键问题,
家族C GPCR,特别是G蛋白偶联和激活的机制。解决这些
问题,我们建议获得mGluR 2,mGluR 5和GABABR与其同源物复合的结构
G蛋白和探针的结构的见解,使用分子动力学模拟和诱变耦合到
功能测定这些受体-G蛋白复合物之间的相似性和差异将使我们能够
对比和比较我们的研究结果,并检查G蛋白偶联和选择性方面。总的来说,
这些研究将使我们能够建立一个详细的机制框架,以了解家族C GPCR
信号传导,并将形成针对这些受体的新的治疗策略的设计的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Georgios Skiniotis其他文献
Georgios Skiniotis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Georgios Skiniotis', 18)}}的其他基金
Mechanistic Basis of Calcium Sensing Receptor Signaling
钙传感受体信号传导的机制基础
- 批准号:
10467554 - 财政年份:2022
- 资助金额:
$ 6.06万 - 项目类别:
Mechanistic Basis of Calcium Sensing Receptor Signaling
钙传感受体信号传导的机制基础
- 批准号:
10596176 - 财政年份:2022
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Family C GPCRs
通过 C 族 GPCR 激发信号的结构基础
- 批准号:
10583455 - 财政年份:2021
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Family C GPCRs
通过 C 族 GPCR 激发信号的结构基础
- 批准号:
10456480 - 财政年份:2021
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Family C GPCRs
通过 C 族 GPCR 激发信号的结构基础
- 批准号:
10368110 - 财政年份:2021
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Family C GPCRs
通过 C 族 GPCR 激发信号的结构基础
- 批准号:
10456501 - 财政年份:2021
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
通过代谢型谷氨酸受体信号激发的结构基础
- 批准号:
9928579 - 财政年份:2019
- 资助金额:
$ 6.06万 - 项目类别:
Architectural Basis of Leptin Transmembrane Signaling
瘦素跨膜信号传导的结构基础
- 批准号:
9486433 - 财政年份:2017
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
通过代谢型谷氨酸受体信号激发的结构基础
- 批准号:
9266501 - 财政年份:2015
- 资助金额:
$ 6.06万 - 项目类别:
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
通过代谢型谷氨酸受体信号激发的结构基础
- 批准号:
9063626 - 财政年份:2015
- 资助金额:
$ 6.06万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 6.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 6.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 6.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)